"7.2.4.1  Summary of evidence and recommendations for lymph node dissection, the management of RCC",
Recommendations,Strength rating
Offer AS to patients with biopsy-proven oncocytoma or other oncocytic renal   tumours as an acceptable alternative to surgery or ablation.,Weak
Offer systemic therapy (everolimus) to patients at need for therapy with surgically   unresectable AMLs not amendable to embolisation or surgery.,Weak
